Bagchi A, Dhanda SK, Dunphy P, et al. Molecular classification improves therapeutic options for infants and young children with medulloblastoma. J Natl Compr Canc Netw 2023;21:1097–1105.

• PubMed
Bagchi A, Dhanda SK, Dunphy P, Molecular classification improves therapeutic options for infants and young children with medulloblastoma. J Natl Compr Canc Netw 2023;21:1097–1105.)| false
• Search Google Scholar
• Export Citation

Michalski JM, Janss AJ, Vezina LG, et al. Children's Oncology Group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2021;39:2685–2697.

• PubMed
Michalski JM, Janss AJ, Vezina LG, Children's Oncology Group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2021;39:2685–2697.)| false
• Search Google Scholar
• Export Citation

Gajjar A, Robinson GW, Smith KS, et al. Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03). J Clin Oncol 2021;39:822–835.

• PubMed
Gajjar A, Robinson GW, Smith KS, Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03). J Clin Oncol 2021;39:822–835.)| false
• Search Google Scholar
• Export Citation

Leary SES, Packer RJ, Li Y, et al. Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma: a randomized clinical trial from the Children’s Oncology Group. JAMA Oncol 2021;7:1313–1321.

• PubMed
Leary SES, Packer RJ, Li Y, Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma: a randomized clinical trial from the Children’s Oncology Group. JAMA Oncol 2021;7:1313–1321.)| false
• Search Google Scholar
• Export Citation

van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3:237–243.

• PubMed
van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3:237–243.)| false
• Search Google Scholar
• Export Citation

Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725–1731.

• PubMed
Duffner PK, Horowitz ME, Krischer JP, Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725–1731.)| false
• Search Google Scholar
• Export Citation

Cohen KJ, Munjapara V, Aguilera D, et al. A pilot study omitting radiation in the treatment of children with newly diagnosed Wnt-activated medulloblastoma. Clin Cancer Res. Published online July 27, 2023. doi:10.1158/1078-0432.CCR-23-0348

• PubMed
Cohen KJ, Munjapara V, Aguilera D, A pilot study omitting radiation in the treatment of children with newly diagnosed Wnt-activated medulloblastoma. Clin Cancer Res. Published online July 27, 2023. doi:10.1158/1078-0432.CCR-23-0348)| false
• Search Google Scholar
• Export Citation

Kahalley LS, Peterson R, Ris MD, et al. Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol 2020;38:454–461.

• PubMed
Kahalley LS, Peterson R, Ris MD, Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol 2020;38:454–461.)| false
• Search Google Scholar
• Export Citation

Mazewski C, Kang G, Kellie S, et al. MBCL-34. Efficacy of methotrexate (MTX) according to molecular subtype in young children with medulloblastoma (MB): a report from the Children’s Oncology Group phase III trial ACNS0334. Neuro Oncol 2020;22(Suppl 3):iii396.

• PubMed
Mazewski C, Kang G, Kellie S, MBCL-34. Efficacy of methotrexate (MTX) according to molecular subtype in young children with medulloblastoma (MB): a report from the Children’s Oncology Group phase III trial ACNS0334. Neuro Oncol 2020;22(Suppl 3):iii396.)| false
• Search Google Scholar
• Export Citation

Leary SES, Kilburn L, Geyer JR, et al. Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: a report from the Pediatric Brain Tumor Consortium (PBTC-026). Neuro Oncol 2022;24:1178–1190.

• PubMed
Leary SES, Kilburn L, Geyer JR, Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: a report from the Pediatric Brain Tumor Consortium (PBTC-026). Neuro Oncol 2022;24:1178–1190.)| false
• Search Google Scholar
• Export Citation

Leary SES, Onar-Thomas A, Fangusaro J, et al. Children's Oncology Group's 2023 blueprint for research: central nervous system tumors. Pediatr Blood Cancer. Published online August 3, 2023. doi:10.1002/pbc.30600

• PubMed
Leary SES, Onar-Thomas A, Fangusaro J, Children's Oncology Group's 2023 blueprint for research: central nervous system tumors. Pediatr Blood Cancer. Published online August 3, 2023. doi:10.1002/pbc.30600)| false
• Search Google Scholar
• Export Citation

Erker C, Mynarek M, Bailey S, et al. Outcomes of infants and young children with relapsed medulloblastoma after initial craniospinal irradiation-sparing approaches: an international cohort study. J Clin Oncol 2023;41:1921–1932.

• PubMed
Erker C, Mynarek M, Bailey S, Outcomes of infants and young children with relapsed medulloblastoma after initial craniospinal irradiation-sparing approaches: an international cohort study. J Clin Oncol 2023;41:1921–1932.)| false
• Search Google Scholar
• Export Citation

Jones C, Straathof K, Fouladi M, et al. Evaluating preclinical evidence for clinical translation in childhood brain tumours: guidelines from the CONNECT, PNOC, and ITCC brain networks. Front Oncol. Published online April 5, 2023. doi:10.3389/fonc.2023.1167082

• PubMed
Jones C, Straathof K, Fouladi M, Evaluating preclinical evidence for clinical translation in childhood brain tumours: guidelines from the CONNECT, PNOC, and ITCC brain networks. Front Oncol. Published online April 5, 2023. doi:10.3389/fonc.2023.1167082)| false
• Search Google Scholar
• Export Citation